— Know what they know.
/
Not Investment Advice
Also trades as: CLS.TO (TSX) · $vol 116M

CLS NYSE

Celestica Inc.
1W: -18.0% 1M: -32.6% 3M: -29.7% YTD: -18.6% 1Y: -12.9% 3Y: +845.4% 5Y: +2559.5%
$276.29
+29.64 (+12.02%)
After Hours: $275.94 (-0.36, -0.13%)
Weekly Expected Move ±9.1%
$212 $236 $260 $284 $307
NYSE · Technology · Hardware, Equipment & Parts · Tech Score Sell · Power 38 · $31.1B mcap · 114M float · 2.08% daily turnover · Short 38% of daily vol
Credit Risk of going bust: lower than 51% of companies Debt: 2.5% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $1.05 (down 99.6%), Celestica Inc. would be worth roughly what it owes.
Total debt $810.4M against a stock market value of $31.07B.
Distance to default 5.23 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $418.4M (short-term plus half of long-term), stock volatility 78.7%; Altman Z'' 2.53. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings
Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest Supply Chain

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
56.6 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 39.3%  ·  5Y Avg: 20.2%
Cost Advantage
63
Intangibles
35
Switching Cost
55
Network Effect
60
Scale ★
83
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. CLS has a Narrow competitive edge (56.6/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Efficient Scale. ROIC of 39.3% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$422
Low
$445
Avg Target
$460
High
Based on 32 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 19Hold: 9Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$445.09
Analysts11
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-10-23 BMO Capital Thanos Moschopoulos $450 $400 -50 +52.0% $263.23
2026-09-30 Bernstein Daniel Zhu Initiated $520 — +41.9% $366.47
2026-09-15 FBN Securities Shebly Seyrafi Initiated $375 — +18.6% $316.08
2026-08-23 UBS David Vogt $410 $430 +20 +45.0% $296.55
2026-08-07 Barclays Tim Long $430 $406 -24 +29.1% $314.53
2026-07-29 RBC Capital Paul Treiber $440 $450 +10 +37.0% $328.43
2026-07-29 CIBC — $480 $500 +20 +56.5% $319.57
2026-07-29 UBS David Vogt $350 $410 +60 +22.5% $334.83
2026-07-29 Barclays — $441 $430 -11 +22.8% $350.20
2026-07-29 Wolfe Research George Notter Initiated $475 — +35.6% $350.20
2026-07-28 Stifel Nicolaus — $445 $500 +55 +42.8% $350.08
2026-05-01 Redburn Partners — Initiated $460 — +12.3% $409.59
2026-04-29 CIBC — $360 $480 +120 +30.7% $367.13
2026-04-29 RBC Capital Paul Treiber $400 $440 +40 +22.2% $360.16
2026-04-29 Susquehanna — Initiated $510 — +41.0% $361.71
2026-04-29 TD Securities — $350 $430 +80 +18.9% $361.71
2026-04-29 Barclays Tim Long $391 $441 +50 +21.9% $361.71
2026-04-28 Goldman Sachs — $440 $475 +35 +31.3% $361.71
2026-04-28 Stifel Nicolaus Ruben Roy $385 $445 +60 +23.0% $361.71
2026-04-24 BMO Capital — $370 $450 +80 +10.9% $405.75
2026-04-20 TD Securities — $305 $350 +45 -11.6% $396.01
2026-03-11 CIBC Todd Coupland $315 $360 +45 +34.7% $267.23
2026-01-30 Barclays — $359 $391 +32 +30.3% $300.00
2025-11-14 Barclays — $357 $359 +2 +22.6% $292.75
2025-10-29 New Street — Initiated $400 — +15.5% $346.25
2025-10-29 RBC Capital — $315 $400 +85 +15.4% $346.69
2025-10-29 UBS — $208 $350 +142 +1.2% $345.86
2025-10-29 Stifel Nicolaus — $140 $385 +245 +17.9% $326.45
2025-10-29 TD Securities — $238 $305 +67 -10.6% $341.18
2025-10-29 BMO Capital — $72 $370 +298 +13.3% $326.45
2025-10-29 Goldman Sachs Michael Ng Initiated $440 — +34.8% $326.45
2025-10-29 Barclays Tim Long Initiated $357 — +9.4% $326.45
2025-10-22 RBC Capital Paul Treiber $140 $315 +175 +19.0% $264.69
2025-10-20 CIBC — Initiated $315 — +15.4% $273.00
2025-10-03 TD Securities — Initiated $238 — -5.1% $250.91
2025-09-25 BNP Paribas — Initiated $300 — +22.6% $244.64
2025-07-30 UBS — Initiated $208 — +2.8% $202.41
2025-02-03 Stifel Nicolaus Ruben Roy $58 $140 +82 +15.8% $120.88
2025-01-31 RBC Capital Paul Treiber $75 $140 +65 +13.4% $123.47
2024-10-24 BMO Capital Thanos Moschopoulos Initiated $72 — +8.3% $66.51
2024-10-24 RBC Capital Maxim Matushansky Initiated $75 — +30.5% $57.47
2024-07-26 Argus Research Kristina Ruggeri Initiated $58 — +10.1% $52.67
2024-07-26 Stifel Nicolaus Matthew Sheerin $51 $58 +7 +13.6% $51.07
2024-07-26 Canaccord Genuity Robert Young Initiated $70 — +37.1% $51.07
2024-05-15 US Capital Advisors Steven Fox Initiated $60 — +25.0% $48.00
2024-05-13 Stifel Nicolaus Matthew Sheerin Initiated $51 — +8.5% $46.99

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B
Oct 27, 2026
DCF
2
ROE
4
ROA
4
D/E
3
P/E
2
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. CLS receives an overall rating of B. Strongest factors: ROE (4/5), ROA (4/5). Areas of concern: DCF (2/5), P/E (2/5), P/B (2/5).
Rating Change History
DateFromTo
2026-10-12 B+ B
2026-10-06 B B+
2026-10-01 B+ B
2026-04-29 B B+
2026-04-28 B+ B
2026-04-28 B B+
2026-03-30 B+ B
2026-02-17 B B+
2026-01-30 B+ B
2026-01-20 B B+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 66 Grade A
Profitability
45
Balance Sheet
88
Earnings Quality
73
Growth
79
Value
31
Momentum
96
Safety
100
Cash Flow
56
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. CLS scores highest in Safety (100/100) and lowest in Value (31/100). An overall grade of A places CLS among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
4.78
Safe Zone
Piotroski F-Score
6/9
✓ ✓ ✓ ✓ ✓ ✓ ✗ ✗ ✗
Beneish M-Score
-2.01
Unlikely Manipulator
Ohlson O-Score
-8.34
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AA+
Score: 94.6/100
Trend: Improving
Earnings Quality
100/100
OCF/NI: 1.13x
Accruals: -1.5%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. CLS scores 4.78, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CLS scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. CLS's score of -2.01 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CLS's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CLS receives an estimated rating of AA+ (score: 94.6/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). CLS's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
28.49x
PEG
0.25x
P/S
2.24x
P/B
12.84x
P/FCF
80.34x
P/OCF
31.18x
EV/EBITDA
24.76x
EV/Revenue
2.24x
EV/EBIT
38.79x
EV/FCF
74.60x
Earnings Yield
2.84%
FCF Yield
1.24%
Shareholder Yield
0.13%
Graham Number
$108.53
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 28.5x earnings, CLS commands a growth premium. Graham's intrinsic value formula yields $108.53 per share, 127% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.856
NI / EBT
×
Interest Burden
1.385
EBT / EBIT
×
EBIT Margin
0.058
EBIT / Rev
×
Asset Turnover
1.682
Rev / Assets
×
Equity Multiplier
2.638
Assets / Equity
=
ROE
30.3%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CLS's ROE of 30.3% is driven by Asset Turnover (1.682), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
15.00%
Fair P/E
38.50x
Intrinsic Value
$395.09
Price/Value
0.91x
Margin of Safety
8.52%
Premium
-8.52%
Assessment
Neutral
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with CLS's realized 15.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. CLS actually compounded EPS at 82.2% over three years; the model uses 15%, the highest rate it will extrapolate — of 4,457 company-quarters that grew faster than 200%, none sustained it over the following seven years. CLS trades at a -9% premium to its adjusted intrinsic value of $395.09, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 38.5x compares to the current market P/E of 28.5x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$246.27
Median 1Y
$346.65
5th Pctile
$121.69
95th Pctile
$988.12
Ann. Volatility
58.9%
Analyst Target
$445.09
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
29,591
+10.2% YoY
Revenue / Employee
$426,069
Rev: $12,607,809,317
Profit / Employee
$28,626
NI: $847,073,356
SGA / Employee
$8,937
Avg labor cost proxy
R&D / Employee
$4,064
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
ROE 7.2% 7.9% 8.4% 8.9% 9.3% 9.4% 10.5% 12.3% 14.2% 18.5% 20.2% 20.4% 22.6% 25.0% 29.4% 36.2% 40.6% 52.5% 52.7% 30.3% 30.33%
ROA 2.5% 2.7% 2.8% 2.9% 2.8% 2.9% 3.2% 3.7% 4.2% 5.6% 6.2% 6.2% 7.0% 7.1% 8.6% 11.1% 12.6% 13.6% 13.9% 11.5% 11.50%
ROIC 6.8% 7.2% 7.8% 8.6% 9.0% 9.4% 10.8% 12.2% 14.0% 16.8% 17.7% 17.6% 20.9% 19.8% 24.8% 25.1% 31.4% 37.0% 39.3% 42.3% 42.27%
ROCE 6.9% 7.6% 8.3% 9.3% 10.2% 11.1% 12.0% 13.1% 14.4% 16.6% 16.9% 17.5% 18.8% 20.3% 24.2% 28.6% 31.7% 37.2% 38.1% 14.3% 14.30%
Gross Margin 9.4% 8.5% 8.7% 8.7% 9.1% 8.9% 9.5% 10.1% 10.4% 10.1% 10.6% 10.4% 11.4% 10.3% 12.8% 11.6% 11.5% 10.8% 12.3% 11.0% 10.99%
Operating Margin 3.3% 2.6% 3.7% 4.1% 4.0% 3.2% 4.5% 5.7% 5.5% 5.7% 5.6% 5.5% 7.7% 4.9% 9.4% 6.7% 8.8% 6.7% 9.8% 7.9% 7.89%
Net Margin 2.1% 1.4% 2.1% 2.4% 2.1% 1.3% 2.9% 3.9% 3.9% 4.2% 4.0% 3.7% 5.3% 3.3% 7.3% 8.4% 7.3% 5.2% 7.8% 6.8% 6.81%
EBITDA Margin 5.6% 4.9% 5.7% 5.9% 5.8% 5.3% 6.6% 7.7% 7.6% 7.0% 6.9% 7.4% 7.3% 6.2% 10.9% 11.4% 10.0% 7.7% 10.8% 7.9% 7.89%
FCF Margin 3.1% 2.6% 2.8% 2.5% 2.6% 2.8% 3.1% 3.4% 3.8% 4.0% 3.4% 3.6% 2.7% 2.8% 3.2% 2.9% 3.7% 3.6% 3.3% 3.0% 3.00%
OCF Margin 4.0% 3.6% 3.9% 3.9% 4.1% 4.5% 4.9% 5.0% 5.4% 5.6% 5.0% 5.3% 4.4% 4.5% 4.7% 4.3% 5.3% 6.4% 7.3% 7.7% 7.72%
ROE 3Y Avg snapshot only 24.80%
ROE 5Y Avg snapshot only 18.94%
ROA 3Y Avg snapshot only 8.31%
ROIC Economic snapshot only 19.47%
Cash ROA snapshot only 9.32%
Cash ROIC snapshot only 45.96%
CROIC snapshot only 17.84%
NOPAT Margin snapshot only 7.10%
Pretax Margin snapshot only 7.98%
R&D / Revenue snapshot only 0.93%
SGA / Revenue snapshot only 2.00%
SBC / Revenue snapshot only 0.34%
Valuation
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
P/E Ratio 13.37 12.89 9.68 7.67 9.48 10.57 10.36 14.46 14.30 17.20 19.49 16.76 26.18 22.59 34.54 40.97 41.10 33.96 37.93 35.22 28.485
P/S Ratio 0.25 0.25 0.19 0.15 0.19 0.21 0.23 0.37 0.44 0.64 0.78 0.66 1.12 0.91 1.71 2.54 2.76 2.36 2.71 2.41 2.239
P/B Ratio 0.95 0.98 0.79 0.66 0.82 0.95 1.04 1.69 1.98 3.13 3.80 3.34 5.71 5.92 10.29 14.08 15.49 15.53 17.10 7.08 12.841
P/FCF 7.96 9.44 6.86 6.05 7.30 7.50 7.21 10.95 11.49 16.10 22.99 18.14 42.21 32.62 53.28 86.96 74.56 66.14 81.53 80.34 80.339
P/OCF 6.12 6.96 4.95 3.95 4.63 4.68 4.61 7.48 8.14 11.52 15.74 12.37 25.33 20.49 36.01 59.23 51.76 36.70 36.98 31.18 31.185
EV/EBITDA 6.11 6.09 4.81 3.92 4.39 4.72 4.73 6.72 7.19 9.79 11.52 9.91 16.15 14.20 21.84 28.38 28.51 24.25 27.51 24.76 24.762
EV/Revenue 0.32 0.32 0.26 0.22 0.25 0.27 0.28 0.43 0.49 0.71 0.84 0.72 1.16 0.99 1.76 2.59 2.79 2.39 2.73 2.24 2.236
EV/EBIT 10.71 10.43 8.02 6.33 6.80 7.18 7.05 9.72 10.19 13.27 15.21 13.12 20.09 17.66 26.35 32.78 33.35 27.91 31.05 38.79 38.792
EV/FCF 10.29 12.25 9.36 8.55 9.48 9.68 8.95 12.59 12.84 17.67 24.73 19.76 43.67 35.37 54.93 88.83 75.25 66.94 82.06 74.60 74.604
Earnings Yield 7.5% 7.8% 10.3% 13.0% 10.5% 9.5% 9.6% 6.9% 7.0% 5.8% 5.1% 6.0% 3.8% 4.4% 2.9% 2.4% 2.4% 2.9% 2.6% 2.8% 2.84%
FCF Yield 12.6% 10.6% 14.6% 16.5% 13.7% 13.3% 13.9% 9.1% 8.7% 6.2% 4.3% 5.5% 2.4% 3.1% 1.9% 1.1% 1.3% 1.5% 1.2% 1.2% 1.24%
PEG Ratio snapshot only 0.247
Price/Tangible Book snapshot only 7.796
EV/OCF snapshot only 28.959
EV/Gross Profit snapshot only 19.625
Acquirers Multiple snapshot only 26.963
Shareholder Yield snapshot only 0.13%
Graham Number snapshot only $108.53
Leverage & Solvency
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Current Ratio 1.52 1.51 1.45 1.43 1.42 1.43 1.43 1.43 1.40 1.42 1.47 1.47 1.49 1.43 1.44 1.47 1.44 1.26 1.23 1.61 1.614
Quick Ratio 0.77 0.70 0.67 0.61 0.65 0.61 0.63 0.70 0.75 0.78 0.86 0.87 0.91 0.85 0.86 0.88 0.88 0.73 0.68 1.03 1.034
Debt/Equity 0.55 0.52 0.53 0.50 0.47 0.47 0.47 0.46 0.44 0.49 0.53 0.52 0.42 0.69 0.50 0.45 0.41 0.37 0.33 0.13 0.132
Net Debt/Equity 0.28 0.29 0.29 0.27 0.25 0.28 0.25 0.25 0.23 0.31 0.29 0.30 0.20 0.50 0.32 0.30 0.14 0.19 0.11 -0.51 -0.506
Debt/Assets 0.17 0.16 0.16 0.15 0.14 0.14 0.14 0.14 0.13 0.15 0.16 0.16 0.13 0.18 0.14 0.14 0.13 0.09 0.08 0.05 0.054
Debt/EBITDA 2.73 2.49 2.35 2.12 1.93 1.81 1.71 1.58 1.44 1.38 1.49 1.41 1.15 1.53 1.02 0.90 0.75 0.57 0.52 0.50 0.496
Net Debt/EBITDA 1.39 1.39 1.28 1.15 1.01 1.06 0.92 0.87 0.76 0.87 0.81 0.81 0.54 1.10 0.66 0.60 0.26 0.29 0.18 -1.90 -1.903
Interest Coverage 5.29 5.51 5.25 4.76 4.41 3.94 3.80 4.23 4.97 6.38 7.79 8.95 13.18 13.47 17.48 22.10 19.70 21.51 21.93 21.08 21.079
Equity Multiplier 3.19 3.21 3.36 3.41 3.35 3.30 3.27 3.31 3.33 3.34 3.26 3.26 3.16 3.75 3.55 3.26 3.25 3.94 3.95 2.44 2.436
Cash Ratio snapshot only 0.510
Debt Service Coverage snapshot only 33.023
Cash to Debt snapshot only 4.838
FCF to Debt snapshot only 0.669
Defensive Interval snapshot only 5075.1 days
Efficiency & Turnover
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Asset Turnover 1.35 1.42 1.41 1.43 1.41 1.46 1.46 1.42 1.38 1.49 1.54 1.58 1.62 1.75 1.75 1.79 1.88 1.96 1.95 1.68 1.682
Inventory Turnover 3.69 3.53 3.43 3.28 3.27 3.16 3.16 3.11 3.22 3.44 3.75 4.05 4.46 4.81 4.98 5.13 5.56 5.47 5.19 4.94 4.943
Receivables Turnover 4.79 5.40 5.45 5.82 5.46 6.01 6.16 5.70 4.99 5.42 5.49 5.12 4.99 5.11 5.06 5.06 5.28 5.21 5.55 5.90 5.899
Payables Turnover 4.92 4.83 4.63 4.75 4.94 5.00 5.06 5.08 5.24 5.50 5.96 6.10 6.65 6.51 6.35 6.48 6.95 5.47 5.10 4.82 4.823
DSO 76 68 67 63 67 61 59 64 73 67 66 71 73 71 72 72 69 70 66 62 61.9 days
DIO 99 103 106 111 112 116 115 118 113 106 97 90 82 76 73 71 66 67 70 74 73.8 days
DPO 74 76 79 77 74 73 72 72 70 66 61 60 55 56 58 56 53 67 72 76 75.7 days
Cash Conversion Cycle 101 95 94 97 105 103 103 110 117 107 103 101 100 91 88 87 82 70 64 60 60.0 days
Fixed Asset Turnover snapshot only 11.443
Operating Cycle snapshot only 135.7 days
Cash Velocity snapshot only 4.616
Capital Intensity snapshot only 0.828
Growth (YoY)
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Revenue -2.0% 5.3% 12.0% 22.0% 28.7% 26.0% 23.6% 17.0% 9.8% 10.8% 13.5% 17.5% 21.2% 21.0% 20.5% 21.7% 28.7% 36.9% 47.5% 62.6% 62.60%
Net Income 71.5% 55.0% 42.6% 46.6% 40.0% 28.8% 35.2% 50.2% 68.1% 1.1% 1.1% 78.8% 69.1% 30.9% 49.2% 92.2% 1.0% 1.4% 1.1% 79.3% 79.32%
EPS 77.4% 60.4% 46.8% 49.3% 42.8% 32.1% 39.3% 54.7% 72.2% 1.1% 1.1% 79.9% 72.2% 33.5% 53.7% 97.2% 1.0% 1.4% 1.1% 70.6% 70.63%
FCF -6.5% 3.5% 20.6% 11.5% 8.2% 33.0% 37.8% 56.3% 61.2% 59.2% 23.0% 25.2% -15.8% -15.2% 14.1% -2.0% 79.2% 74.5% 53.1% 66.9% 66.86%
EBITDA 16.4% 20.8% 25.0% 35.6% 38.8% 35.6% 33.9% 34.2% 33.3% 40.1% 39.5% 33.3% 27.4% 16.9% 33.6% 53.8% 74.9% 93.4% 81.6% 60.6% 60.62%
Op. Income 31.1% 33.3% 35.9% 51.1% 57.0% 52.8% 49.9% 49.5% 45.5% 59.4% 61.0% 48.4% 54.0% 31.9% 48.1% 57.5% 59.2% 82.6% 73.2% 87.4% 87.43%
OCF Growth snapshot only 1.93%
Asset Growth snapshot only 1.29%
Equity Growth snapshot only 2.06%
Debt Growth snapshot only -11.12%
Shares Change snapshot only 5.09%
Growth (CAGR)
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Revenue 3Y -5.3% -3.1% -0.3% 3.1% 7.2% 9.2% 10.0% 10.3% 11.5% 13.7% 16.2% 18.8% 19.6% 19.1% 19.1% 18.7% 19.6% 22.5% 26.3% 32.5% 32.49%
Revenue 5Y -1.3% -0.6% 0.1% 1.6% 3.4% 4.1% 4.3% 4.0% 3.7% 4.9% 6.8% 8.6% 10.4% 11.8% 12.7% 14.0% 16.6% 19.5% 22.8% 27.1% 27.12%
EPS 3Y 5.1% -10.3% -4.9% 0.8% 29.5% — — 87.0% 63.4% 65.5% 62.6% 60.8% 61.8% 55.7% 65.1% 76.4% 82.2% 89.4% 90.1% 82.2% 82.23%
EPS 5Y -2.6% -0.0% 2.1% 7.2% 10.2% 12.3% 19.9% 34.9% 23.4% 15.3% 20.3% 23.3% 45.2% — — 87.5% 72.6% 70.5% 69.7% 69.5% 69.48%
Net Income 3Y 1.7% -13.0% -6.6% -0.6% 27.4% — — 82.3% 59.2% 61.3% 59.0% 57.9% 58.5% 52.4% 61.4% 72.8% 78.9% 86.3% 88.0% 83.3% 83.35%
Net Income 5Y -5.3% -2.9% -1.1% 3.7% 6.5% 8.7% 16.2% 30.7% 19.9% 12.2% 18.1% 21.4% 42.5% — — 83.5% 68.9% 66.8% 66.5% 68.5% 68.47%
EBITDA 3Y 14.6% 2.5% 5.3% 8.2% 12.8% 32.1% 31.4% 29.6% 29.2% 31.9% 32.7% 34.3% 33.1% 30.5% 35.7% 40.1% 43.8% 46.9% 50.1% 48.8% 48.77%
EBITDA 5Y 3.6% 4.9% 7.5% 10.3% 13.1% 15.0% 18.1% 22.0% 22.7% 15.4% 16.9% 17.8% 19.5% 30.4% 33.4% 34.8% 36.9% 39.0% 41.5% 43.1% 43.05%
Gross Profit 3Y 4.2% 6.9% 9.6% 13.7% 18.3% 19.8% 20.7% 20.3% 21.2% 23.1% 25.6% 27.8% 28.1% 27.6% 29.5% 30.0% 31.3% 33.9% 37.1% 41.1% 41.10%
Gross Profit 5Y 2.6% 3.4% 4.8% 6.7% 8.7% 10.2% 11.6% 12.4% 12.6% 14.5% 16.8% 18.9% 21.6% 22.6% 24.5% 25.1% 26.9% 29.0% 31.7% 35.3% 35.34%
Op. Income 3Y 16.4% -1.3% 4.8% 11.4% 20.8% 73.5% 61.8% 49.6% 44.2% 48.1% 48.6% 49.6% 52.1% 47.6% 52.9% 51.7% 52.8% 56.6% 60.4% 63.6% 63.61%
Op. Income 5Y 1.4% 3.1% 6.7% 10.1% 12.8% 16.1% 21.1% 27.8% 29.2% 18.6% 22.7% 25.1% 31.6% 61.5% 58.8% 50.9% 49.0% 50.9% 53.1% 58.1% 58.14%
FCF 3Y — 84.4% 9.9% -2.2% -10.6% -9.7% -3.6% 7.3% 17.7% 29.9% 26.9% 29.7% 13.7% 21.5% 24.6% 24.2% 34.5% 33.1% 29.0% 27.0% 26.97%
FCF 5Y 9.8% 0.5% -3.3% 19.2% 50.6% — — — — 67.7% 17.6% 12.8% -0.6% -0.1% 4.7% 8.7% 19.7% 26.5% 29.0% 28.9% 28.95%
OCF 3Y 89.9% 24.8% 4.3% -0.5% -4.8% -2.1% 4.5% 13.8% 21.5% 31.4% 30.2% 32.6% 23.5% 28.2% 27.3% 22.5% 30.5% 38.4% 44.7% 53.3% 53.25%
OCF 5Y 5.5% -1.3% -3.2% 9.0% 18.6% 31.2% 88.5% 37.9% 67.0% 33.5% 15.1% 13.0% 4.4% 4.7% 8.7% 12.6% 22.5% 34.1% 42.2% 46.3% 46.29%
Assets 3Y 7.7% 9.5% 12.3% 14.6% 16.5% 15.6% 13.2% 14.9% 17.1% 17.2% 16.2% 13.8% 8.7% 6.4% 6.7% 7.3% 8.6% 14.7% 21.2% 38.1% 38.12%
Assets 5Y 10.4% 11.5% 12.5% 13.2% 13.7% 12.9% 11.4% 11.6% 9.5% 9.2% 10.1% 10.7% 11.0% 10.5% 10.5% 11.8% 14.5% 18.4% 21.2% 30.3% 30.33%
Equity 3Y 3.2% 2.7% 3.7% 4.8% 7.3% 7.3% 7.2% 7.4% 7.9% 6.7% 8.1% 7.4% 9.0% 1.0% 4.7% 8.9% 9.7% 8.2% 13.8% 53.0% 52.96%
Book Value 3Y 6.7% 5.9% 5.6% 6.2% 9.1% 9.5% 9.8% 10.2% 10.7% 9.5% 10.5% 9.3% 11.3% 3.2% 7.1% 11.2% 11.7% 10.0% 15.2% 52.0% 52.03%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Revenue Stability 0.31 0.26 0.11 0.01 0.16 0.27 0.28 0.28 0.30 0.44 0.60 0.70 0.80 0.86 0.89 0.91 0.90 0.88 0.86 0.82 0.819
Earnings Stability 0.41 0.08 0.03 0.02 0.13 0.02 0.15 0.47 0.62 0.35 0.49 0.62 0.83 0.95 0.92 0.84 0.81 0.78 0.80 0.84 0.836
Margin Stability 0.88 0.88 0.87 0.87 0.87 0.87 0.85 0.85 0.85 0.84 0.84 0.84 0.83 0.83 0.82 0.83 0.84 0.85 0.86 0.87 0.867
Rev. Growth Consistency 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.50 0.50 0.50 0.81 0.84 0.88 0.86 0.50 0.50 0.50 0.50 0.50 0.50 0.88 0.80 0.50 0.50 0.50 0.50 0.50 0.500
Earnings Smoothness 0.47 0.57 0.65 0.62 0.67 0.75 0.70 0.60 0.49 0.29 0.30 0.43 0.49 0.73 0.61 0.37 0.33 0.19 0.28 0.43 0.432
ROE Trend 0.02 0.06 0.05 0.04 0.03 0.03 0.03 0.04 0.06 0.10 0.10 0.10 0.11 0.13 0.15 0.19 0.20 0.24 0.20 -0.07 -0.070
Gross Margin Trend 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.02 0.01 0.01 0.01 0.00 0.004
FCF Margin Trend -0.01 -0.01 -0.01 -0.01 -0.01 0.00 0.00 0.01 0.01 0.01 0.00 0.01 -0.01 -0.01 -0.00 -0.01 0.00 0.00 0.00 -0.00 -0.003
Sustainable Growth Rate 7.2% 7.9% 8.4% 8.9% 9.3% 9.4% 10.5% 12.3% 14.2% 18.5% 20.2% 20.4% 22.6% 25.0% 29.4% 36.2% 40.6% 52.5% 52.7% 30.3% 30.33%
Internal Growth Rate 2.6% 2.8% 2.9% 3.0% 2.9% 3.0% 3.3% 3.8% 4.4% 5.9% 6.6% 6.6% 7.5% 7.6% 9.5% 12.5% 14.5% 15.8% 16.2% 13.0% 12.99%
Cash Flow Quality
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
OCF/Net Income 2.18 1.85 1.96 1.94 2.05 2.26 2.25 1.93 1.76 1.49 1.24 1.35 1.03 1.10 0.96 0.69 0.79 0.93 1.03 1.13 1.129
FCF/OCF 0.77 0.74 0.72 0.65 0.63 0.62 0.64 0.68 0.71 0.72 0.68 0.68 0.60 0.63 0.68 0.68 0.69 0.55 0.45 0.39 0.388
FCF/Net Income snapshot only 0.438
OCF/EBITDA snapshot only 0.855
CapEx/Revenue 0.9% 0.9% 1.1% 1.4% 1.5% 1.7% 1.8% 1.6% 1.6% 1.6% 1.6% 1.7% 1.8% 1.7% 1.5% 1.4% 1.6% 2.9% 4.0% 4.7% 4.72%
CapEx/Depreciation snapshot only 6.299
Accruals Ratio -0.03 -0.02 -0.03 -0.03 -0.03 -0.04 -0.04 -0.03 -0.03 -0.03 -0.01 -0.02 -0.00 -0.01 0.00 0.03 0.03 0.01 -0.00 -0.01 -0.015
Sloan Accruals snapshot only 0.275
Cash Flow Adequacy snapshot only 1.634
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio 34.6% 33.3% 28.0% 16.7% 23.8% 25.2% 25.3% 18.5% 14.6% 13.3% 10.4% 37.6% 36.8% 52.3% 46.4% 20.2% 18.1% 10.0% 5.0% 4.7% 4.71%
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 2.6% 2.6% 2.9% 2.2% 2.5% 2.4% 2.4% 1.3% 1.0% 0.8% 0.5% 2.2% 1.4% 2.3% 1.3% 0.5% 0.4% 0.3% 0.1% 0.1% 0.13%
Net Buyback Yield 2.6% 2.6% 2.9% 2.2% 2.5% 2.4% 2.4% 1.3% 1.0% 0.7% 0.5% 2.2% 1.4% 2.3% 1.3% 0.5% 0.4% 0.3% 0.1% -7.6% -7.57%
Total Shareholder Return 2.6% 2.6% 2.9% 2.2% 2.5% 2.4% 2.4% 1.3% 1.0% 0.7% 0.5% 2.2% 1.4% 2.3% 1.3% 0.5% 0.4% 0.3% 0.1% -7.6% -7.57%
DuPont Factors
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Tax Burden (NI/EBT) 0.76 0.76 0.75 0.74 0.71 0.70 0.74 0.77 0.80 0.83 0.83 0.81 0.80 0.78 0.78 0.82 0.85 0.85 0.85 0.86 0.856
Interest Burden (EBT/EBIT) 0.81 0.82 0.81 0.79 0.77 0.75 0.74 0.76 0.80 0.84 0.87 0.89 0.92 0.93 0.94 0.95 0.95 0.95 0.95 1.39 1.385
EBIT Margin 0.03 0.03 0.03 0.03 0.04 0.04 0.04 0.04 0.05 0.05 0.06 0.05 0.06 0.06 0.07 0.08 0.08 0.09 0.09 0.06 0.058
Asset Turnover 1.35 1.42 1.41 1.43 1.41 1.46 1.46 1.42 1.38 1.49 1.54 1.58 1.62 1.75 1.75 1.79 1.88 1.96 1.95 1.68 1.682
Equity Multiplier 2.90 2.88 3.00 3.08 3.28 3.26 3.31 3.36 3.34 3.32 3.27 3.28 3.24 3.53 3.40 3.26 3.21 3.86 3.78 2.64 2.638
Per Share
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
EPS (Diluted TTM) $0.83 $0.92 $1.00 $1.10 $1.19 $1.22 $1.40 $1.70 $2.05 $2.61 $2.94 $3.05 $3.53 $3.49 $4.52 $6.01 $7.19 $8.30 $9.62 $10.26 $10.26
Book Value/Share $11.72 $12.10 $12.34 $12.74 $13.71 $13.61 $13.97 $14.52 $14.82 $14.35 $15.10 $15.30 $16.16 $13.32 $15.17 $17.50 $19.09 $18.13 $21.34 $51.02 $21.56
Tangible Book/Share $5.99 $6.51 $6.79 $7.24 $8.19 $8.20 $8.58 $9.17 $9.41 $9.06 $9.48 $9.75 $10.58 $7.86 $9.75 $12.19 $13.93 $13.05 $16.37 $46.36 $46.36
Revenue/Share $45.15 $47.85 $50.51 $54.54 $59.23 $61.85 $64.36 $65.74 $66.62 $69.84 $73.57 $77.72 $82.23 $86.28 $91.35 $97.03 $107.09 $119.36 $134.38 $150.13 $135.60
FCF/Share $1.40 $1.26 $1.42 $1.39 $1.54 $1.72 $2.01 $2.24 $2.55 $2.79 $2.49 $2.82 $2.19 $2.42 $2.93 $2.83 $3.96 $4.26 $4.47 $4.50 $4.51
OCF/Share $1.82 $1.71 $1.97 $2.13 $2.43 $2.75 $3.14 $3.28 $3.60 $3.90 $3.64 $4.13 $3.64 $3.85 $4.33 $4.16 $5.71 $7.67 $9.87 $11.59 $9.95
Cash/Share $3.16 $2.78 $2.95 $2.95 $3.06 $2.62 $3.00 $2.95 $3.10 $2.58 $3.63 $3.35 $3.61 $2.59 $2.71 $2.64 $5.13 $3.27 $4.61 $32.52 $4.66
EBITDA/Share $2.36 $2.54 $2.76 $3.03 $3.33 $3.53 $3.81 $4.19 $4.55 $5.04 $5.35 $5.62 $5.91 $6.02 $7.37 $8.87 $10.47 $11.76 $13.35 $13.55 $13.55
Debt/Share $6.42 $6.32 $6.49 $6.43 $6.42 $6.38 $6.51 $6.61 $6.56 $6.98 $7.97 $7.92 $6.79 $9.22 $7.55 $7.95 $7.89 $6.68 $6.97 $6.72 $6.72
Net Debt/Share $3.27 $3.54 $3.54 $3.48 $3.36 $3.75 $3.51 $3.66 $3.46 $4.40 $4.34 $4.56 $3.18 $6.63 $4.84 $5.31 $2.76 $3.41 $2.36 $-25.80 $-25.80
Academic Models
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 4.776
Altman Z-Prime snapshot only 7.716
Piotroski F-Score 6 6 6 7 7 8 8 8 8 7 8 8 9 8 7 7 7 7 6 6 6
Beneish M-Score -2.37 -2.16 -2.34 -2.33 -2.43 -2.65 -2.61 -2.36 -2.45 -2.27 -2.21 -2.41 -2.29 -2.42 -2.27 -2.09 -2.07 -1.91 -1.95 -2.01 -2.007
Ohlson O-Score snapshot only -8.343
ROIC (Greenblatt) snapshot only 16.54%
Net-Net WC snapshot only $29.71
EVA snapshot only $991143683.59
Credit
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Credit Rating snapshot only AA+
Credit Score 48.25 47.71 48.02 44.78 47.83 46.87 58.16 58.09 58.21 66.94 70.27 69.36 80.21 74.84 85.10 88.25 92.66 93.72 93.88 94.61 94.615
Credit Grade snapshot only 2
Credit Trend snapshot only 6.369
Implied Spread (bps) snapshot only 65.000
Industry Credit Rank snapshot only 88
Sector Credit Rank snapshot only 84

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms